Brief: Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate

Aptorum

09/09/2019 12:20

Sept 9 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP HAS INITIATED IND-ENABLING STUDIES FOR ITS
ALS-4
SMALL MOLECULE CANDIDATE FOR THE TREATMENT OF INFECTIONS CAUSED
BY STAPHYLOCOCCUS AUREUS INCLUDING MRSA

Source text for Eikon:  ID:nBw7dtp8Ba 
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))